Biological mechanisms and clinical implications of endocrine resistance in breast cancer
Mario Giuliano(Regione Campania), Meghana V. Trivedi(University of Houston), Rachel Schiff(Baylor College of Medicine), C. Kent Osborne(Texas Oncology)
Cited by 111
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545
Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
|Cancer Research|2008|494